Cutting funding doesn’t just affect current treatment—it halts crucial research progress.

The 3 October 2024 decision to remove neurofeedback funding creates a chilling effect on autism treatment research. Ongoing studies face disruption, data collection becomes impossible, and research momentum is lost as participants can no longer access the therapy being studied. This interruption affects our understanding of autism support far beyond the immediate funding cut.

Research setbacks create gaps in our knowledge that may take years to fill.

When studies are forced to stop mid-progress, we lose more than just current data—we lose the opportunity to build a comprehensive understanding of treatment effectiveness. Longitudinal studies particularly suffer, as interrupted access makes it impossible to track long-term outcomes.

Each disrupted study represents lost potential for improving autism support.

The impact extends beyond neurofeedback research—it affects our broader understanding of autism treatment approaches. When promising research directions are abandoned due to funding cuts, we lose pathways to developing more effective support options.

We must protect the research that advances autism support.

Reinstating neurofeedback funding isn’t just about current treatment—it’s about maintaining the research momentum necessary for developing better autism support options for the future.